| Consensus: guidelines for diagnosis and therapy of MEN type 1 and type 2 ML Brandi, RF Gagel, A Angeli, JP Bilezikian, P Beck-Peccoz, C Bordi, ... The Journal of clinical endocrinology & metabolism 86 (12), 5658-5671, 2001 | 2615 | 2001 |
| Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis JY Reginster, HW Minne, OH Sorensen, M Hooper, C Roux, ML Brandi, ... Osteoporosis international 11, 83-91, 2000 | 2146 | 2000 |
| Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1) RV Thakker, PJ Newey, GV Walls, J Bilezikian, H Dralle, PR Ebeling, ... The Journal of clinical endocrinology & metabolism 97 (9), 2990-3011, 2012 | 1599 | 2012 |
| Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus AA Khan, A Morrison, DA Hanley, D Felsenberg, LK McCauley, F O'Ryan, ... Journal of Bone and Mineral Research 30 (1), 3-23, 2015 | 1567 | 2015 |
| Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop JP Bilezikian, ML Brandi, R Eastell, SJ Silverberg, R Udelsman, ... The Journal of Clinical Endocrinology & Metabolism 99 (10), 3561-3569, 2014 | 1514 | 2014 |
| Romosozumab or alendronate for fracture prevention in women with osteoporosis KG Saag, J Petersen, ML Brandi, AC Karaplis, M Lorentzon, T Thomas, ... New England Journal of Medicine 377 (15), 1417-1427, 2017 | 1374 | 2017 |
| Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture K Estrada, U Styrkarsdottir, E Evangelou, YH Hsu, EL Duncan, EE Ntzani, ... Nature genetics 44 (5), 491-501, 2012 | 1338 | 2012 |
| Intravenous zoledronic acid in postmenopausal women with low bone mineral density IR Reid, JP Brown, P Burckhardt, Z Horowitz, P Richardson, U Trechsel, ... New England Journal of Medicine 346 (9), 653-661, 2002 | 1140 | 2002 |
| 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension HG Bone, RB Wagman, ML Brandi, JP Brown, R Chapurlat, ... The lancet Diabetes & endocrinology 5 (7), 513-523, 2017 | 991 | 2017 |
| Sarcopenia in daily practice: assessment and management C Beaudart, E McCloskey, O Bruyère, M Cesari, Y Rolland, R Rizzoli, ... BMC geriatrics 16, 1-10, 2016 | 974 | 2016 |
| An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: a report from a task force of the European Society for Clinical and … O Bruyère, C Cooper, JP Pelletier, J Branco, ML Brandi, F Guillemin, ... Seminars in arthritis and rheumatism 44 (3), 253-263, 2014 | 901 | 2014 |
| Pitfalls in the measurement of muscle mass: a need for a reference standard F Buckinx, F Landi, M Cesari, RA Fielding, M Visser, K Engelke, S Maggi, ... Journal of cachexia, sarcopenia and muscle 9 (2), 269-278, 2018 | 786 | 2018 |
| Oxidative stress in bone remodeling: role of antioxidants V Domazetovic, G Marcucci, T Iantomasi, ML Brandi, MT Vincenzini Clinical Cases in Mineral and Bone Metabolism 14 (2), 209, 2017 | 735 | 2017 |
| ENETS consensus guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes RT Jensen, G Cadiot, ML Brandi, WW De Herder, G Kaltsas, P Komminoth, ... Neuroendocrinology 95 (2), 98-119, 2012 | 686 | 2012 |
| Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target‐organ involvement, treatment, and challenges for future research JP Bilezikian, A Khan, JT Potts Jr, ML Brandi, BL Clarke, D Shoback, ... Journal of Bone and Mineral Research 26 (10), 2317-2337, 2011 | 683 | 2011 |
| Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus AA Khan, DA Hanley, R Rizzoli, J Bollerslev, JEM Young, L Rejnmark, ... Osteoporosis International 28, 1-19, 2017 | 641 | 2017 |
| Quality of life in sarcopenia and frailty R Rizzoli, JY Reginster, JF Arnal, I Bautmans, C Beaudart, ... Calcified tissue international 93, 101-120, 2013 | 539 | 2013 |
| Strontium ranelate: dose-dependent effects in established postmenopausal vertebral osteoporosis—a 2-year randomized placebo controlled trial PJ Meunier, DO Slosman, PD Delmas, JL Sebert, ML Brandi, C Albanese, ... The Journal of Clinical Endocrinology & Metabolism 87 (5), 2060-2066, 2002 | 536 | 2002 |
| Does nutrition play a role in the prevention and management of sarcopenia? SM Robinson, JY Reginster, R Rizzoli, SC Shaw, JA Kanis, I Bautmans, ... Clinical Nutrition 37 (4), 1121-1132, 2018 | 526 | 2018 |
| Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia D Haffner, F Emma, L Seefried, W Högler, KM Javaid, D Bockenhauer, ... Nature Reviews Nephrology, 1-25, 2025 | 495 | 2025 |
